Ainsworth Sean
CIK: 0001830296
Director
Primary company: Opus Genetics, Inc. (IRD)
Ainsworth Sean is a corporate insider at Opus Genetics, Inc. (IRD) filing SEC Form 4 transactions. 18 transactions. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 24,367 | - | - | 321,692 | 4/20/2026 Filed: 4/22/2026 | Filing → | |
| Award | 86,956 | $1.15 | $100K | 254,818 | 8/25/2025 Filed: 8/27/2025 | Filing → | |
| Award | 79,592 | - | - | 79,592 | 4/30/2025 Filed: 5/2/2025 | Filing → | |
| Award | 79,504 | - | - | 167,862 | 4/30/2025 Filed: 5/2/2025 | Filing → | |
Ocuphire Pharma, Inc. OCUP | Award | 35,181 | - | - | 35,181 | 6/11/2024 Filed: 6/13/2024 | Filing → |
Ocuphire Pharma, Inc. OCUP | Award | 41,143 | - | - | 88,358 | 6/11/2024 Filed: 6/13/2024 | Filing → |
Ocuphire Pharma, Inc. OCUP | Award | 9,639 | $0.00 | $0 | 9,639 | 6/6/2023 Filed: 6/8/2023 | Filing → |
Ocuphire Pharma, Inc. OCUP | Award | 10,976 | $0.00 | $0 | 47,215 | 6/6/2023 Filed: 6/8/2023 | Filing → |
Ocuphire Pharma, Inc. OCUP | X | 1,574 | $0.00 | $0 | 0 | 10/19/2022 Filed: 10/20/2022 | Filing → |
Ocuphire Pharma, Inc. OCUP | X | 1,574 | $0.00 | $0 | 41,239 | 10/19/2022 Filed: 10/20/2022 | Filing → |
Ocuphire Pharma, Inc. OCUP | Award | 20,000 | $0.00 | $0 | 20,000 | 6/13/2022 Filed: 6/15/2022 | Filing → |
Ocuphire Pharma, Inc. OCUP | Award | 20,000 | $0.00 | $0 | 20,000 | 6/7/2021 Filed: 6/9/2021 | Filing → |
Ocuphire Pharma, Inc. OCUP | Purchase | 1,574 | - | - | 1,574 | 11/19/2020 Filed: 11/25/2020 | Filing → |
Ocuphire Pharma, Inc. OCUP | Purchase | 13,394 | - | - | 13,394 | 11/19/2020 Filed: 11/25/2020 | Filing → |
Ocuphire Pharma, Inc. OCUP | Purchase | 8,865 | - | - | 44,665 | 11/19/2020 Filed: 11/25/2020 | Filing → |
Ocuphire Pharma, Inc. OCUP | Award | 5,000 | $0.00 | $0 | 5,000 | 11/11/2020 Filed: 11/13/2020 | Filing → |
Ocuphire Pharma, Inc. OCUP | Award | 52,825 | - | - | 52,825 | 11/5/2020 Filed: 11/9/2020 | Filing → |
Ocuphire Pharma, Inc. OCUP | Award | 35,663 | - | - | 35,663 | 11/5/2020 Filed: 11/9/2020 | Filing → |
Ocuphire Pharma, Inc. OCUP | Award | 35,800 | - | - | 35,800 | 11/5/2020 Filed: 11/9/2020 | Filing → |
Type
Award
Shares
24,367
Price
-
Value
-
Type
Award
Shares
86,956
Price
$1.15
Value
$100K
Type
Award
Shares
79,592
Price
-
Value
-
Type
Award
Shares
79,504
Price
-
Value
-
Ocuphire Pharma, Inc.
OCUP
Type
Award
Shares
35,181
Price
-
Value
-
Ocuphire Pharma, Inc.
OCUP
Type
Award
Shares
41,143
Price
-
Value
-
Ocuphire Pharma, Inc.
OCUP
Type
Award
Shares
9,639
Price
$0.00
Value
$0
Ocuphire Pharma, Inc.
OCUP
Type
Award
Shares
10,976
Price
$0.00
Value
$0
Ocuphire Pharma, Inc.
OCUP
Type
X
Shares
1,574
Price
$0.00
Value
$0
Ocuphire Pharma, Inc.
OCUP
Type
X
Shares
1,574
Price
$0.00
Value
$0
Ocuphire Pharma, Inc.
OCUP
Type
Award
Shares
20,000
Price
$0.00
Value
$0
Ocuphire Pharma, Inc.
OCUP
Type
Award
Shares
20,000
Price
$0.00
Value
$0
Ocuphire Pharma, Inc.
OCUP
Type
Purchase
Shares
1,574
Price
-
Value
-
Ocuphire Pharma, Inc.
OCUP
Type
Purchase
Shares
13,394
Price
-
Value
-
Ocuphire Pharma, Inc.
OCUP
Type
Purchase
Shares
8,865
Price
-
Value
-
Ocuphire Pharma, Inc.
OCUP
Type
Award
Shares
5,000
Price
$0.00
Value
$0
Ocuphire Pharma, Inc.
OCUP
Type
Award
Shares
52,825
Price
-
Value
-
Ocuphire Pharma, Inc.
OCUP
Type
Award
Shares
35,663
Price
-
Value
-
Ocuphire Pharma, Inc.
OCUP
Type
Award
Shares
35,800
Price
-
Value
-
AI Agent
Try asking...